Green Thumb Industries Inc. (OTCMKTS:GTBIF - Free Report) - Atb Cap Markets cut their FY2025 earnings per share estimates for Green Thumb Industries in a research note issued to investors on Thursday, August 28th. Atb Cap Markets analyst F. Gomes now anticipates that the company will post earnings per share of $0.06 for the year, down from their prior forecast of $0.08. The consensus estimate for Green Thumb Industries' current full-year earnings is $0.32 per share.
Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.04 by ($0.05). Green Thumb Industries had a return on equity of 1.62% and a net margin of 2.51%.The firm had revenue of $293.26 million during the quarter, compared to analysts' expectations of $280.66 million.
Separately, Benchmark restated a "buy" rating on shares of Green Thumb Industries in a research note on Monday, August 11th. Two equities research analysts have rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. According to MarketBeat, the company presently has an average rating of "Strong Buy".
Check Out Our Latest Stock Analysis on GTBIF
Green Thumb Industries Trading Down 1.4%
Shares of GTBIF stock opened at $8.69 on Monday. Green Thumb Industries has a 12-month low of $4.63 and a 12-month high of $11.50. The business's fifty day simple moving average is $6.71 and its 200-day simple moving average is $6.12. The company has a market cap of $1.84 billion, a PE ratio of 79.01 and a beta of 1.22.
About Green Thumb Industries
(
Get Free Report)
Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Green Thumb Industries, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Green Thumb Industries wasn't on the list.
While Green Thumb Industries currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.